高级检索
当前位置: 首页 > 详情页

The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Southwest Med Univ, Sch Pharm, Luzhou, Peoples R China [2]Sichuan Acad Chinese Med Sci, Sichuan Inst Translat Chinese Med, Sichuan Engn Technol Res Ctr Genuine Reg Drug, Sichuan Prov Engn Res Ctr Format Principle & Qual, Chengdu, Peoples R China [3]Univ Elect Sci & Technol China, Radiat Oncol Key Lab Sichuan Prov, Sichuan Canc Ctr, Dept Radiat Oncol,Sichuan Clin Res Ctr Canc,Affili, Chengdu, Peoples R China [4]Chengdu Univ, Coll Food & Biol Engn, Chengdu, Peoples R China [5]Southwest Med Univ, Tradit Chinese Med Hosp, Class Chinese Med Diag & Treatment Ctr, Luzhou, Peoples R China
出处:
ISSN:

关键词: gut microbiome cancer immunology immunotherapy tumor microenvironment immunomodulation

摘要:
The gut microbiota is not just a simple nutritional symbiosis that parasitizes the host; it is a complex and dynamic ecosystem that coevolves actively with the host and is involved in a variety of biological activities such as circadian rhythm regulation, energy metabolism, and immune response. The development of the immune system and immunological functions are significantly influenced by the interaction between the host and the microbiota. The interactions between gut microbiota and cancer are of a complex nature. The critical role that the gut microbiota plays in tumor occurrence, progression, and treatment is not clear despite the already done research. The development of precision medicine and cancer immunotherapy further emphasizes the importance and significance of the question of how the microbiota takes part in cancer development, progression, and treatment. This review summarizes recent literature on the relationship between the gut microbiome and cancer immunology. The findings suggest the existence of a "symbiotic microecosystem" formed by gut microbiota, metabolome, and host immunome that is fundamental for the pathogenesis analysis and the development of therapeutic strategies for cancer.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 2 区 医学
小类 | 2 区 免疫学
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 免疫学
JCR分区:
出版当年[2023]版:
Q1 IMMUNOLOGY
最新[2023]版:
Q1 IMMUNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者:
第一作者机构: [1]Southwest Med Univ, Sch Pharm, Luzhou, Peoples R China [2]Sichuan Acad Chinese Med Sci, Sichuan Inst Translat Chinese Med, Sichuan Engn Technol Res Ctr Genuine Reg Drug, Sichuan Prov Engn Res Ctr Format Principle & Qual, Chengdu, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Southwest Med Univ, Sch Pharm, Luzhou, Peoples R China [2]Sichuan Acad Chinese Med Sci, Sichuan Inst Translat Chinese Med, Sichuan Engn Technol Res Ctr Genuine Reg Drug, Sichuan Prov Engn Res Ctr Format Principle & Qual, Chengdu, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43378 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号